在倾向性得分分析中不可靠的持续治疗指标
1Strategic Research Development, UF Research, University of Florida.
Multivariate behavioral research
|July 31, 2023
概括
在倾向性评分分析 (PSA) 中,复合可靠性较低,可能会低估治疗效果. 使用与共变量估计的因子得分可能有助于在通用倾向得分 (GPS) 模型中减轻这种偏差.
科学领域:
- 统计 统计 统计 统计
- 流行病学 流行病学
- 教育研究教育研究
背景情况:
- 倾向性评分分析 (PSA) 通常使用连续治疗的复合措施,通常没有报告复合可靠性.
- 这些复合指标的不可靠性对PSA治疗效果估计的影响尚不清楚.
- 隐性变量或因子得分方法,这些方法可以解释测量误差,很少被用作替代方法.
研究的目的:
- 通过使用通用倾向得分 (GPS) 进行倾向得分分析,研究潜伏连续处理中的指标不可靠性的影响.
- 评估复合可靠性如何影响偏差,根平均平方误差 (RMSE) 和平均治疗效应 (ATE) 估计的覆盖率.
主要方法:
- 采用蒙特卡洛模拟研究,操纵诸如复合可靠性,治疗表现,因子负载变化,样本大小和治疗指标数量的因素.
- 用通用倾向分数 (GPS) 建模共变量与连续治疗之间的关系.
- 在各种模拟条件下,根据相对偏差,RMSE和覆盖率来评估ATE估计.
主要成果:
- 发现较低的复合可靠性系统地低估了潜在连续治疗的ATE.
- 处理指标的数量和因子负载的变化对ATE估计的影响很小,一旦考虑了整体复合可靠性.
- 在正确指定的GPS模型中,使用包含共变量的因子得分有助于减少由复合材料可靠性低造成的偏差.
结论:
- 复合指标的可靠性是获得持续治疗PSA中ATE精确估计的关键因素.
- 研究人员应该考虑测量不可靠性的影响,并探索潜变量方法或因子得分,特别是当共变量可以被整合到他们的估计时.
- 这些发现对涉及复杂或多指标治疗变量的观察性研究的设计和分析有影响.
相关概念视频
Censoring Survival Data
132
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
132
Truncation in Survival Analysis
237
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
237
Sign Test for Matched Pairs
162
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
162
Confounding in Epidemiological Studies
190
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
190
Bias in Epidemiological Studies
353
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
353
Kaplan-Meier Approach
180
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
180


